71 related articles for article (PubMed ID: 11719991)
21. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase.
Yano S; Kazuno H; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T
Bioorg Med Chem; 2004 Jul; 12(13):3431-41. PubMed ID: 15186829
[TBL] [Abstract][Full Text] [Related]
22. [The selective toxic effect of dialdehyde derivatives of the pyrimidine nucleosides on human tumor cells].
Efremova AS; Shram SI; Drenichev MS; Posypanova GA; Myasoedov NF; Mihaylov SN
Biomed Khim; 2015; 61(4):497-502. PubMed ID: 26350741
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiherpesviral activity of 5-C-substituted uracil nucleosides.
Sakata S; Shibuya S; Machida H; Yoshino H; Hirota K; Senda S; Ikeda K; Mizuno Y
Nucleic Acids Symp Ser; 1980; (8):s39-42. PubMed ID: 6265881
[TBL] [Abstract][Full Text] [Related]
24. Effect of the N-glycosidic bond conformation and modifications in the pentose moiety on the binding of nucleoside ligands to uridine phosphorylase.
el Kouni MH; Naguib FN; Chu SH; Cha SM; Ueda T; Gosselin G; Imbach JL; Shealy YF; Otter BA
Mol Pharmacol; 1988 Aug; 34(2):104-10. PubMed ID: 3412318
[TBL] [Abstract][Full Text] [Related]
25. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
Katahira R; Ashihara H
Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
[TBL] [Abstract][Full Text] [Related]
26. Role of thymidine kinase and thymidylate synthetase in the cytostatic, antimetabolic, and antitumor effects of the carbocyclic analogue of 5-nitro-2'-deoxyuridine. A comparison with 5-nitro-2'-deoxyuridine.
Balzarini J; De Clercq E; Herdewijn P; Robins MJ
Mol Pharmacol; 1985 May; 27(5):578-83. PubMed ID: 3990680
[TBL] [Abstract][Full Text] [Related]
27. Investigations on the influence of cisplatin on the antitumor effect of novel phosphonate derivatives of uracil and thymine.
Ochocki J; Graczyk J
Pharmazie; 1998 Dec; 53(12):884-5. PubMed ID: 9879574
[No Abstract] [Full Text] [Related]
28. A new antitumor nucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd), is a potent inhibitor of RNA synthesis.
Matsuda A; Fukushima M; Wataya Y; Sasaki T
Nucleosides Nucleotides; 1999; 18(4-5):811-4. PubMed ID: 10432683
[TBL] [Abstract][Full Text] [Related]
29. Design and synthesis of 3'- and 5'-O-(3-benzenesulfonylfuroxan-4-yl)-2'-deoxyuridines: biological evaluation as hybrid nitric oxide donor-nucleoside anticancer agents.
Moharram S; Zhou A; Wiebe LI; Knaus EE
J Med Chem; 2004 Mar; 47(7):1840-6. PubMed ID: 15027876
[TBL] [Abstract][Full Text] [Related]
30. Efficient synthesis of exomethylene- and keto-exomethylene-d-glucopyranosyl nucleoside analogs as potential cytotoxic agents.
Tzioumaki N; Tsoukala E; Manta S; Kiritsis C; Balzarini J; Komiotis D
Carbohydr Res; 2011 Feb; 346(2):328-33. PubMed ID: 21146812
[TBL] [Abstract][Full Text] [Related]
31. Effects of uridine and thymidine on the degradation of 5-fluorouracil, uracil, and thymine by rat liver dihydropyrimidine dehydrogenase.
Tuchman M; Ramnaraine ML; O'Dea RF
Cancer Res; 1985 Nov; 45(11 Pt 1):5553-6. PubMed ID: 4053028
[TBL] [Abstract][Full Text] [Related]
32. Crystal structure and conformation of 5-fluorouridine: conformational preferences for 5-fluorinated pyranosides.
Soni SD; Srikrishnan T
Nucleosides Nucleotides Nucleic Acids; 2004; 23(11):1779-95. PubMed ID: 15598078
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of 5-phosphoribosyl-1-pyrophosphate synthetase by the monophosphate metabolite of 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine: a novel mechanism for antitumor activity.
Fry DW; Boritzki TJ; Jackson RC; Cook PD; Leopold WR
Mol Pharmacol; 1993 Aug; 44(2):479-85. PubMed ID: 7689145
[TBL] [Abstract][Full Text] [Related]
34. Selective cytotoxicity of 5-hydroxyuridine for human colon adenocarcinoma cells.
Lockshin A; Giovanella BC; Mendoza JT; Warneke C; Stehlin JS
Cancer Treat Rep; 1985; 69(7-8):845-50. PubMed ID: 3160461
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of nucleobase-modified analogs of the anticancer compounds 3'-C-ethynyluridine (EUrd) and 3'-C-ethynylcytidine (ECyd).
Hrdlicka PJ; Jepsen JS; Nielsen C; Wengel J
Bioorg Med Chem; 2005 Feb; 13(4):1249-60. PubMed ID: 15670934
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of action of a new antitumor ribonucleoside, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106), differs from that of 5-fluorouracil.
Kazuno H; Shimamoto Y; Tsujimoto H; Fukushima M; Matsuda A; Sasaki T
Oncol Rep; 2007 Jun; 17(6):1453-60. PubMed ID: 17487404
[TBL] [Abstract][Full Text] [Related]
37. Sensitivity of human cancer cells to the new anticancer ribo-nucleoside TAS-106 is correlated with expression of uridine-cytidine kinase 2.
Shimamoto Y; Koizumi K; Okabe H; Kazuno H; Murakami Y; Nakagawa F; Matsuda A; Sasaki T; Fukushima M
Jpn J Cancer Res; 2002 Jul; 93(7):825-33. PubMed ID: 12149149
[TBL] [Abstract][Full Text] [Related]
38. A facile synthesis of 5-(perfluoroalkyl)-pyrimidines.
Cech D; Wohlfeil R; Etzold G
Nucleic Acids Res; 1975 Nov; 2(11):2183-92. PubMed ID: 1052538
[TBL] [Abstract][Full Text] [Related]
39. Fluorination of 6-methyluracil and its nlcleosides.
Cech D; Herrmann G; Holy A
Nucleic Acids Res; 1977 Sep; 4(9):3259-66. PubMed ID: 909805
[TBL] [Abstract][Full Text] [Related]
40. [The preparation of different uridine and uracil dimers].
Fahr E; Fürst G; Pastille R
Z Naturforsch B; 1968 Oct; 23(10):1387-8. PubMed ID: 4387318
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
